Gene Therapy

Biopharma

Our dedicated and experienced teams leverage state-of-the-art equipment and facilities to help develop gene therapy products that are ready for clinical trial.

Gene Therapy Market Size

The global gene therapy market size is evaluated at $710 million as of 2018 and is anticipated to grow with a CAGR of 31.5% throughout the forecast period 2019-2025.

As of the end of 2019 there were 1,000 gene therapies in active or actively recruiting clinical trials and that number is only expected to increase.

Gene Therapy Manufacturing

Our gene therapy services help overcome several hurdles in viral vector manufacturing, including production challenges related to the use of adherent host cell lines, virus stability, and limitations in virus characterization, as well as a lack of appropriate sensors and models to enable closed-loop control and optimization of virus manufacturing processes.

Viral Vector Manufacturing

In recent years, numerous companies have entered clinical trials with viral vectors. However, several challenges continue to exist, including capacity issues related to plasmid and virus production, virus stability, toxicity of the virus to the host cell lines, and limited ability to properly characterize the active virus product. These challenges have impacted consistent supply and product quality. 

NJII’s Gene Therapy Unit addresses several hurdles in viral vector manufacturing, including production challenges related to the use of adherent host cell lines, virus stability, and limitations in virus characterization, as well as a lack of appropriate sensors and models to enable closed-loop control and optimization of virus manufacturing processes.

Get in touch

Tell us about your next project or greatest challenge and we'll contact you to discuss how we can help.

*First and Last Name

*Title

*Company

*Email

*How can we help?